comprehensive -WSS

comprehensive

author：hotspot 2025-09-28 00:51:27 - browse：3943

Photo illustration based on photograph of The University of Texas MD Anderson Cancer Center in Houston, Texas in 2022 — Photo illustration: STAT; Photo: Adobe

Prominent immunologist and oncologist Padmanee Sharma defended herself in court on Friday against a lawsuit that alleges she threatened to undermine a junior faculty member’s career, made defamatory comments about the younger scientist, and attempted to take credit for work that she didn’t do.

In legal filings submitted to the Harris County District Court, Sharma said that she made substantial contributions to an immunotherapy project that were ignored, and that a third-party assessment commissioned by MD Anderson Cancer Center concluded Sharma should be given credit for her role. Sharma had previously issued a general denial of the allegations against her and claimed immunity from the suit as a government employee. As part of the University of Texas, MD Anderson is a state institution.

The filing, which was submitted by Texas Attorney General Ken Paxton and lawyers in his office, also argued that the junior researcher’s lawsuit should be made against MD Anderson, not Sharma, and asked the court to dismiss the suit if it is not amended within 30 days. “Dr. Sharma is not a proper party to this lawsuit; only MDACC is,” the filing states. “This lawsuit is about proper accreditation in scientific literature for research performed at MDACC by MDACC faculty.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： Oprah kicked off a national conversation on obesity. Let's have it

explore

WSS

FDA approves Eli Lilly ulcerative colitis treatment Omvoh

Chimpanzees, like humans and whales, get menopause: Study

Donor acceptance rates hint at racial, gender bias in heart transplants: study

Readout Newsletter: What happened with Sarepta's Duchenne data

FDA approves Eli Lilly ulcerative colitis treatment Omvoh

Readout Newsletter: Blackstone Life Sciences, Merck, Bluebird Bio

Wikipedia

comprehensive

explore

Guidelines to prevent youth baseball injuries need more muscle

Abortion pill case raises question: who can sue the FDA?

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Washington mulls new rules to avert another Change Healthcare

New air purifier tech could be key to improving indoor air quality

FDA's naming rule on biosimilars has undermined competition

Dobbs anniversary: the lost opportunity of abortion as health care

Oprah kicked off a national conversation on obesity. Let's have it

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Why Sanofi got shellacked over its spinoff

entertainment

There's no autism epidemic. It's an autism diagnosis epidemic

Readout Newsletter: The latest from Bristol, Sarepta, and Novartis

The FDA weighs the risks of candy

Oprah kicked off a national conversation on obesity. Let's have it

Food as medicine: Medically tailored meals may get standardized

Steward Health Care has deal to sell doctor network to UnitedHealth

hotspot

leisure time

explore

knowledge